All In Biotech

Drug Trial Radar · NCT00421863

Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study

Last checked: Nov 19, 2026Latest source record: Feb 3, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,111 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,111

Actual

Start

Feb 2005

Primary completion

Jan 2009

Study completion Jan 2009

Sponsor

Lead sponsor
Heart Care FoundationAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 15, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Multicenter, prospective, randomised, open study comparing the effect of the following two strategies in hypertensive subjects \> 55 years and poorly controlled (systolic blood pressure \>= 150 mmHg) by antihypertensive treatment: * usual strategy: reduction of systolic blood pressure to below 140 mmHg, independently of diastolic blood pressure levels; * intensive strategy: reduction of systolic blood pressure to below 130 mmHg, independently of diastolic blood pressure levels. During the initial run in period two qualifying visits at distance of 7-14 days will be carried out to establish whether blood pressure remains uncontrolled (systolic blood pressure \>=150 mmHg)by current drug treatment. At the end of the second visit eligible patients will be admitted to the study and the following examinations will be carried out: clinical visit, routine laboratory tests, 12-lead ECG. At this point eligible patients will be randomised to one of the two blood pressure goals outlined above. Subsequent clinical visits will be carried out at 4 month-intervals up to the end of the study (4, 8, 12, 16, 20, 24 months).

Conditions

  • Hypertension

Interventions

  • Triatec 10 mgDrug

    Use and dosage according to physician judgement, concomitant treatment assumed and randomization arm (Intensive Strategy vs. Usual Strategy).

  • Triatec HCT 5Drug

    Use and dosage according to physician judgement, concomitant treatment assumed and randomization arm (Intensive Strategy vs. Usual Strategy).

  • Lasix 25Drug

    Use and dosage according to physician judgement, concomitant treatment assumed and randomization arm (Intensive Strategy vs. Usual Strategy).

  • Micardis 80 mgDrug

    Use and dosage according to physician judgement, concomitant treatment assumed and randomization arm (Intensive Strategy vs. Usual Strategy).

  • Micardis plus 80/12.5Drug

    Use and dosage according to physician judgement, concomitant treatment assumed and randomization arm (Intensive Strategy vs. Usual Strategy).

  • Catapresan TTS 2Drug

    Use and dosage according to physician judgement, concomitant treatment assumed and randomization arm (Intensive Strategy vs. Usual Strategy).

  • Norvasc 10 mgDrug

    Use and dosage according to physician judgement, concomitant treatment assumed and randomization arm (Intensive Strategy vs. Usual Strategy).

  • Triatec 5 mgDrug

    Use and dosage according to physician judgement, concomitant treatment assumed and randomization arm (Intensive Strategy vs. Usual Strategy).

  • PluscorDrug

    Use and dosage according to physician judgement, concomitant treatment assumed and randomization arm (Intensive Strategy vs. Usual Strategy).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. changes in Left Ventricular Hypertrophy (LVH) at Electro Cardio Gramme (ECG).Time frame: 0, 12, 24 months

Locations

45 sites in 1 country. Site status is shown where the registry gives one.

  • Ospedale Generale Regionale

    Aosta, Italy

  • Azienda Ospedaliera G. Rummo

    Benevento, Italy

  • Spedali Civili

    Brescia, Italy

  • Azienda Ospedaliera G. Brotzu - S. Michele

    Cagliari, Italy

  • Ospedale S. Elia

    Caltanissetta, Italy

  • Ospedale Garibaldi-Nesima

    Catania, Italy

  • Azienda Ospedaliera Mater Domini

    Catanzaro, Italy

  • Ospedale Clinicizzato Santissima Annunziata

    Chieti, Italy

  • Istituti Ospitalieri

    Cremona, Italy

  • Dimi - Disem

    Genova, Italy

  • Ospedale Generale Provinciale

    Gorizia, Italy

  • Policlinico Universitario Federico II

    Naples, Italy

  • Azienda Ospedaliera di Perugia

    Perugia, Italy

  • Spedali Riuniti

    Pistoia, Italy

  • Ospedale Civile

    Ragusa, Italy

  • Ospedali Riuniti G. Melacrino F. Bianchi

    Reggio Calabria, Italy

  • Ospedale San Filippo Neri

    Roma, Italy

  • CTO

    Roma, Italy

  • Ospedlae San Camillo

    Roma, Italy

  • Ospedale San Camillo

    Roma, Italy

  • Ospedale San Giovanni

    Roma, Italy

  • Policlinico Universitario

    Sassari, Italy

  • Azienda Ospedaliera

    Syracuse, Italy

  • Azienda USL 4 Terni

    Terni, Italy

  • Ospedale San Vito

    Torino, Italy

  • Casa di Cura Villa Bianca

    Trento, Italy

  • Ospedale Belcolle

    Viterbo, Italy

  • Ospedale N. Melli

    San Pietro Vernotico, Brindisi, Italy

  • Ospedale Civile Mellini

    Chiari, BS, Italy

  • Ospedale Civile G. Chidichimo

    Trebisacce, Cosenza, Italy

  • Istituto Neuromed

    Pozzilli, Isernia, Italy

  • Presidio Ospedaliero F. Ferrari

    Casarano, Lecce, Italy

  • Nuovo Ospedale Versilia

    Lido di Camaiore, Lucca, Italy

  • Ospedale Civile

    Castiglione del Lago, Perugia, Italy

  • Ospedale Civile Beato Giacomo Villa

    Città della Pieve, Perugia, Italy

  • Presidio Ospedaliero Città di Castello

    Città di Castello, Perugia, Italy

  • Ospedale Civile

    Gubbio, Perugia, Italy

  • Presidio Ospedaliero

    Todi, Perugia, Italy

  • Ospedale Silvestrini

    Perugia, PG, Italy

  • Ospedale Civile

    Sacile, Pordenone, Italy

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.